<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The report from the 2nd Consensus Committee on BrS suggests that <z:hpo ids='HP_0000001'>all</z:hpo> patients with <z:hpo ids='HP_0001279'>syncope</z:hpo> without a "clear extracardiac cause" should have an implantable cardioverter-defibrillator (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>However, a clear extracardiac cause for <z:hpo ids='HP_0001279'>syncope</z:hpo> may be difficult to prove </plain></SENT>
<SENT sid="2" pm="."><plain>OBJECTIVE: The purpose of this study was to characterize <z:hpo ids='HP_0001279'>syncope</z:hpo> in patients with <z:e sem="disease" ids="C1142166" disease_type="Disease or Syndrome" abbrv="SUNDS">Brugada syndrome</z:e> (BrS) </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: <z:hpo ids='HP_0000001'>All</z:hpo> patients diagnosed with BrS at our institution between 1999 and 2010 were enrolled in a prospective registry </plain></SENT>
<SENT sid="4" pm="."><plain>Patients with suspected arrhythmic <z:hpo ids='HP_0001279'>syncope</z:hpo> (group 1) were compared to patients with nonarrhythmic <z:hpo ids='HP_0001279'>syncope</z:hpo> (group 2) and to patients with <z:hpo ids='HP_0001279'>syncope</z:hpo> of doubtful origin (group 3) </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Of 203 patients with BrS, 57 (28%; 44 male, age 46 ± 12 years) experienced at least 1 <z:hpo ids='HP_0001279'>syncope</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Group 1 consisted of 23 patients, <z:hpo ids='HP_0000001'>all</z:hpo> of whom received an <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>In group 2 (17 patients), 3 received an <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> because of a positive electrophysiologic study </plain></SENT>
<SENT sid="8" pm="."><plain>In group 3 (17 patients), 6 received an implantable loop recorder and 6 received an <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>After mean follow-up of 65 ± 42 months, 14 patients in group 1 remained asymptomatic, 4 had recurrent <z:hpo ids='HP_0001279'>syncope</z:hpo>, and 6 had appropriate <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> therapy </plain></SENT>
<SENT sid="10" pm="."><plain>In group 2, 9 patients remained asymptomatic and 7 had recurrent neurocardiogenic <z:hpo ids='HP_0001279'>syncope</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>In group 3, 7 remained asymptomatic and 9 had recurrent <z:hpo ids='HP_0001279'>syncope</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>One patient from each group died from a noncardiac cause </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSION: In the present study, <z:hpo ids='HP_0001279'>syncope</z:hpo> occurred in 28% of patients with BrS </plain></SENT>
<SENT sid="14" pm="."><plain>The <z:hpo ids='HP_0004308'>ventricular arrhythmia</z:hpo> rate was 5.5% per year in group 1 </plain></SENT>
<SENT sid="15" pm="."><plain>In 30%, the etiology of the <z:hpo ids='HP_0001279'>syncope</z:hpo> was questionable </plain></SENT>
<SENT sid="16" pm="."><plain>No <z:hpo ids='HP_0001645'>sudden cardiac death</z:hpo> occurred in groups 2 and 3 </plain></SENT>
</text></document>